［1］ Warburg O.On the origin of cancer cells ［J］.Science,1956,123(3191):309-314.
［2］ Hanahan D,Weinberg RA.Hallmarks of cancer:The next generation［J］.Cell,2011,144(5)：646-674.
［3］ Jones NP,Schulze A.Targeting cancer metabolism-aiming at a tumour's sweet-spot［J］.Drug Discovery Today,2012,17(5-6):232-241.
［4］ Locasale JW.The consequences of enhanced cell-autonomous glucose metabolism［J］.Trends in Endocrinology & Metabolism Tem,2012,23(11):545-551.
［5］ Antonov A,Agostini M,Morello M,et al.Bioinformatics analysis of the serine and glycine pathway in cancer cells［J］.Oncotarget,2014,5(22):11004-11013.
［6］ Labuschagne CF,Van den Broek NJ,Mackay GM,et al.Serine,but not glycine,supports one-carbon metabolism and proliferation of cancer cells ［J］.Cell Rep,2014,7(4):1248-1258.
［7］ Kit S.The biosynthesis of free glycine and serine by tumors［J］.Cancer Res,1955,15(11):715-718.
［8］ Murphy JP,Giacomantonio MA,Paulo JA,et al.The NAD+ salvage pathway supports PHGDH-driven serine biosynthesis［J］.Cell Reports,2018,24(9):2381.
［9］ Singh M,Warita K,Warita T,et al.Shift from stochastic to spatially-ordered expression of serine-glycine synthesis enzymes in 3D microtumors［J］.Sci Rep,2018,8(1):9388.
［10］ Possemato R,Marks KM,Shaul YD,et al.Functional genomics reveal that the serine synthesis pathway is essential in breast cancer［J］.Nature,2011,476(7360):346-350.
［11］ Jing Z,Heng W,Aiping D,et al.Expression and clinical significance of phosphoglycerate dehydrogenase and squamous cell carcinoma antigen in cervical cancer［J］.International Journal of Gynecological Cancer,2013,23(8):1465-1469.
［12］ Paone A,Marani M,Fiascarelli A,et al.SHMT1 knockdown induces apoptosis in lung cancer cells by causing uracil misincorporation［J］.Cell Death & Disease,2014,5(11):e1525.
［13］ Woo CC,Chen WC,Teo XQ,et al.Downregulating serine hydroxymethyltransferase 2 (SHMT2) suppresses tumorigenesis in human hepatocellular carcinoma［J］.Oncotarget,2016,7(33):53005-53017.
［14］ Schumacker PT.Reactive oxygen species in cancer:A dance with the devil［J］.Cancer Cell,2015,27(2):156-157.
［15］ Schumacker PT.Reactive oxygen species in cancer cells:Live by the sword,die by the sword ［J］.Cancer Cell,2006,10(3):175-176.
［16］ Liou GY,Storz P.Reactive oxygen species in cancer ［J］.Free Radical Res,2010,44(5):479-496.
［17］ Maddocks OD,Berkers CR,Mason SM,et al.Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells ［J］.Nature,2013,493(7433):542-546.
［18］ Shaw RJ,Cantley LC.Decoding key nodes in the metabolism of cancer cells:Sugar & spice and all things nice［J］.F1000 Biology Reports,2012,4(4):2.
［19］ Pinweha P,Rattanapornsompong K,Charoensawan V,et al.MicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancers［J］.Computational & Structural Biotechnology Journal,2016,14(C):223-233.
［20］ Sun L,Song L,Wan Q,et al.cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions ［J］.Cell Res,2015,25(4):429-444.
［21］ Cho HM,Jun DY,Bae MA,et al.Nucleoide sequence and differential expression of the human 3-phosphoglycerate dehydrogenase gen［J］.Gene,2000,245(1):193-201.
［22］ Kim SK,Jung WH,Koo JS.Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes［J］.PLoS One,2014(9):e101004.
［23］ Ou Y,Wang SJ,Jiang L,et al.p53 Protein-mediated regulation of phosphoglycerate dehydrogenase (PHGDH)is crucial for the apoptotic response upon serine starvation ［J］.J Biol Chem,2015,290(1):457-466.
［24］ Song Z,Feng C,Lu Y,et al.PHGDH is an independent prognosis marker and contributes cell proliferation,migration and invasion in human pancreatic cancer［J］.Gene,2018(642):43-50.
［25］ Li Q,Gao H,Zhou S,et al.LncRNA PlncRNA-1 overexpression inhibits the growth of breast cancer by upregulating TGF-β1 and downregulating PHGDH［J］.Breast Cancer,2018,25(5):619-625.
［26］ Polet F,Corbet C,Pinto A,et al.Reducing the serine availability complements the inhibition of the glutamine metabolism to block leukemia cell growth ［J］.Oncotarget,2016,7(2):1765-1776.
［27］ Liao KM，Chao TB，Tian YF,et al．Overexpression of the PSATl gene in nasopharyngeal carcinoma is an indicator of poor prognosis［J］．J Cancer，2016，7(9)：1088-1094．
［28］ Yan S，Jiang H，Fang S,et al．MicroRNA-340 inhibits esophageal cancer cell growth and invasion by targeting phosphoserine aminotransferase 1［J］．Cell Physiol Biochem,2015,37(1):375-386．
［29］ Yang CS,Stampouloglou E,Kingston NM,et al.Glutamine-utilizing transaminases are a metabolic vulnerability of TAZ/YAP-activated cancer cells［J］.EMBO Rep，2018，19(6):e43577.
［30］ Marchi TD,Timmermans MA,Sieuwerts AM,et al.Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer［J］.Scientific Reports,2017,7(1):2099.
［31］ Qian,Xia,Ren,et al.Identification and validation of PSAT1 as a potential prognostic factor for predicting clinical outcomes in patients with colorectal carcinoma［J］.Oncology Letters,2017,14(6):8014-8020.
［32］ Sun WY,Kim HM,Jung WH,et al.Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype［J］.Journal of Translational Medicine,2016,14(1):168.
［33］ Xin L,Zhe X,Yong Y.Inhibition of phosphoserine phosphatase enhances the anticancer efficacy of 5-fluorouracil in colorectal cancer［J］.Biochemical & Biophysical Research Communications,2016,477(4):633-639.
［34］ Koo JS,Yoon JS.Expression of metabolism-related proteins in lacrimal gland adenoid cystic carcinoma［J］.American Journal of Clinical Pathology,2015,143(4):584-592.
［35］ Lee JY,Lim W,Jo G,et al.Estrogen regulation of phosphoserine phosphatase during regression and recrudescence of female reproductive organs［J］.General & Comparative Endocrinology,2015(214):40-46.
［36］ Sato K,Masuda T,Hu Q,et al.Phosphoserine phosphatase is a novel prognostic biomarker on chromosome 7 in colorectal cancer［J］.Anticancer Research,2017,37(5):2365.
［37］ Locasale JW.Serine,glycineandone-carbonunits:Cancer metabolismin full circle［J］.Nature Reviews Cancer,2013,13(8):572-583.
［38］ Wu X,Deng L,Tang D,et al.miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2(SHMT2) in hepatocellular carcinoma［J］.Tumour Biol,2016,37(5):6813-6821.
［39］ Bernhardt S,Bayerlová M,Vetter M,et al.Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors［J］.Breast Cancer Res,2017,19(1):112.
［40］ Gupta R,Yang Q,Dogra SK,et al.Serine hydroxymethyl transferase 1 stimulates pro-oncogenic cytokine expression through sialic acid to promote ovarian cancer tumor growth and progression［J］.Oncogene,2017,36(28):4014-4024.
［41］ Wu S,Zhang G,Li P,et al.miR-198 targets SHMT1 to inhibit cell proliferation and enhance cell apoptosis in lung adenocarcinoma［J］.Tumour Biol,2016,37(4):5193-5202.
［42］ Ducker GS,Ghergurovich JM,Mainolfi N,et al.Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma ［J］.Proc Natl Acad Sci USA,2017,114(43):11404-11409.